Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial. - Motzer RJ; Martini JF; Mu XJ; Staehler M; George DJ; Valota O; Lin X; Pandha HS; Ching KA; Ravaud A (Nature communications, 2022)